India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward.
India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward.
India and the Patent Wars: Pharmaceuticals in the New Intellectual Property Regime
202India and the Patent Wars: Pharmaceuticals in the New Intellectual Property Regime
202Product Details
ISBN-13: | 9781501713477 |
---|---|
Publisher: | Cornell University Press |
Publication date: | 11/15/2017 |
Series: | The Culture and Politics of Health Care Work |
Pages: | 202 |
Product dimensions: | 5.90(w) x 8.90(h) x 0.30(d) |
Age Range: | 18 Years |